Susan R Heckbert1, Thomas R Austin1, Paul N Jensen2, Lin Y Chen3, Wendy S Post4, James S Floyd1,2, Elsayed Z Soliman5, Richard A Kronmal6, Bruce M Psaty1,2,7,8. 1. Department of Epidemiology (S.R.H., T.R.A., J.S.F., B.M.P.), University of Washington, Seattle. 2. Department of Medicine (P.N.J., J.S.F., B.M.P.), University of Washington, Seattle. 3. Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis (L.Y.C.). 4. Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD (W.S.P.). 5. Epidemiological Cardiology Research Center, Wake Forest University School of Medicine, Winston-Salem, NC (E.Z.S.). 6. Department of Biostatistics (R.A.K.), University of Washington, Seattle. 7. Department of Health Services (B.M.P), University of Washington, Seattle. 8. Kaiser Permanente Health Research Institute, Seattle, WA (B.M.P.).
Abstract
BACKGROUND: African Americans are consistently found to have a lower prevalence of clinically detected atrial fibrillation (AF) than whites, despite a higher prevalence of major AF risk factors and higher risk of ischemic stroke. Long-term ambulatory ECG monitors provide the opportunity for unbiased AF detection. We determined differences by race/ethnicity in the prevalence of clinically detected AF and in the proportion with monitor-detected AF. METHODS: We conducted a cross-sectional analysis in the MESA (Multi-Ethnic Study of Atherosclerosis), a community-based cohort study that enrolled 6814 Americans free of clinically recognized cardiovascular disease in 2000 to 2002. At the 2016 to 2018 examination, 1556 individuals participated in an ancillary study involving ambulatory ECG monitoring and had follow-up for clinically detected AF since cohort entry. RESULTS: Among 1556 participants, 41% were white, 25% African American, 21% Hispanic, and 14% Chinese; 51% were women; and the mean age was 74 years. The prevalence of clinically detected AF after 14.4 years' follow-up was 11.3% in whites, 6.6% in African Americans, 7.8% in Hispanics, and 9.9% in Chinese and was significantly lower in African Americans than in whites, in both unadjusted and risk factor-adjusted analyses (adjusted rate difference, -6.6% [95% CI, -10.1% to -3.1%]; P<0.001). By contrast, in the same individuals, the proportion with monitor-detected AF using a 14-day ambulatory ECG monitor was similar in the 4 race/ethnic groups: 7.1%, 6.4%, 6.9%, and 5.2%, respectively (compared with whites, all P>0.5). CONCLUSIONS: The prevalence of clinically detected AF was substantially lower in African American than in white participants, without or with adjustment for AF risk factors. However, unbiased AF detection by ambulatory monitoring in the same individuals revealed little difference in the proportion with AF by race/ethnicity. These findings provide support for the hypothesis of differential detection by race/ethnicity in the clinical recognition of AF, which may have important implications for stroke prevention.
BACKGROUND: African Americans are consistently found to have a lower prevalence of clinically detected atrial fibrillation (AF) than whites, despite a higher prevalence of major AF risk factors and higher risk of ischemic stroke. Long-term ambulatory ECG monitors provide the opportunity for unbiased AF detection. We determined differences by race/ethnicity in the prevalence of clinically detected AF and in the proportion with monitor-detected AF. METHODS: We conducted a cross-sectional analysis in the MESA (Multi-Ethnic Study of Atherosclerosis), a community-based cohort study that enrolled 6814 Americans free of clinically recognized cardiovascular disease in 2000 to 2002. At the 2016 to 2018 examination, 1556 individuals participated in an ancillary study involving ambulatory ECG monitoring and had follow-up for clinically detected AF since cohort entry. RESULTS: Among 1556 participants, 41% were white, 25% African American, 21% Hispanic, and 14% Chinese; 51% were women; and the mean age was 74 years. The prevalence of clinically detected AF after 14.4 years' follow-up was 11.3% in whites, 6.6% in African Americans, 7.8% in Hispanics, and 9.9% in Chinese and was significantly lower in African Americans than in whites, in both unadjusted and risk factor-adjusted analyses (adjusted rate difference, -6.6% [95% CI, -10.1% to -3.1%]; P<0.001). By contrast, in the same individuals, the proportion with monitor-detected AF using a 14-day ambulatory ECG monitor was similar in the 4 race/ethnic groups: 7.1%, 6.4%, 6.9%, and 5.2%, respectively (compared with whites, all P>0.5). CONCLUSIONS: The prevalence of clinically detected AF was substantially lower in African American than in white participants, without or with adjustment for AF risk factors. However, unbiased AF detection by ambulatory monitoring in the same individuals revealed little difference in the proportion with AF by race/ethnicity. These findings provide support for the hypothesis of differential detection by race/ethnicity in the clinical recognition of AF, which may have important implications for stroke prevention.
Authors: Susan R Heckbert; Thomas R Austin; Paul N Jensen; James S Floyd; Bruce M Psaty; Elsayed Z Soliman; Richard A Kronmal Journal: J Electrocardiol Date: 2018-07-30 Impact factor: 1.438
Authors: Carlos J Rodriguez; Elsayed Z Soliman; Alvaro Alonso; Katrina Swett; Peter M Okin; David C Goff; Susan R Heckbert Journal: Ann Epidemiol Date: 2014-11-28 Impact factor: 3.797
Authors: Jonathan P Piccini; Bradley G Hammill; Moritz F Sinner; Paul N Jensen; Adrian F Hernandez; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis Journal: Circ Cardiovasc Qual Outcomes Date: 2012-01-10
Authors: Chu-Pak Lau; T David Gbadebo; Stuart J Connolly; Isabelle C Van Gelder; Alessandro Capucci; Michael R Gold; Carsten W Israel; Carlos A Morillo; Chung-Wah Siu; Haruhiko Abe; Mark Carlson; Hung-Fat Tse; Stefan H Hohnloser; Jeff S Healey Journal: J Cardiovasc Electrophysiol Date: 2013-01-28
Authors: Isabelle C Van Gelder; Jeff S Healey; Harry J G M Crijns; Jia Wang; Stefan H Hohnloser; Michael R Gold; Alessandro Capucci; Chu-Pak Lau; Carlos A Morillo; Anne H Hobbelt; Michiel Rienstra; Stuart J Connolly Journal: Eur Heart J Date: 2017-05-01 Impact factor: 29.983
Authors: Hooman Kamel; Dawn O Kleindorfer; Prashant D Bhave; Mary Cushman; Emily B Levitan; George Howard; Elsayed Z Soliman Journal: J Am Heart Assoc Date: 2016-02-12 Impact factor: 5.501
Authors: Susan R Heckbert; Kerri L Wiggins; Chad Blackshear; Yi Yang; Jingzhong Ding; Jiankang Liu; Barbara McKnight; Alvaro Alonso; Thomas R Austin; Emelia J Benjamin; Lesley H Curtis; Nona Sotoodehnia; Adolfo Correa Journal: Obesity (Silver Spring) Date: 2017-04-28 Impact factor: 5.002
Authors: Alvaro Alonso; Bouwe P Krijthe; Thor Aspelund; Katherine A Stepas; Michael J Pencina; Carlee B Moser; Moritz F Sinner; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Sunil K Agarwal; David D McManus; Patrick T Ellinor; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Elsayed Z Soliman; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Emelia J Benjamin Journal: J Am Heart Assoc Date: 2013-03-18 Impact factor: 5.501
Authors: Sofia E Gomez; Muhammad Fazal; Julio C Nunes; Shayena Shah; Alexander C Perino; Sanjiv M Narayan; Kamala P Tamirisa; Janet K Han; Fatima Rodriguez; Tina Baykaner Journal: J Interv Card Electrophysiol Date: 2022-10-13 Impact factor: 1.759
Authors: Alka M Kanaya; Ann W Hsing; Sela V Panapasa; Namratha R Kandula; Maria Rosario G Araneta; Daichi Shimbo; Paul Wang; Scarlett L Gomez; Jinkook Lee; K M Venkat Narayan; Marjorie K L Mala Mau; Sonali Bose; Martha L Daviglus; Frank B Hu; Nadia Islam; Chandra L Jackson; Merle Kataoka-Yahiro; John S K Kauwe; Simin Liu; Grace X Ma; Tung Nguyen; Latha Palaniappan; V Wendy Setiawan; Chau Trinh-Shevrin; Janice Y Tsoh; Dhananjay Vaidya; Barbara Vickrey; Thomas J Wang; Nathan D Wong; Sean Coady; Yuling Hong Journal: Ann Intern Med Date: 2022-01-04 Impact factor: 51.598
Authors: Sébastien Thériault; Medea Imboden; Mary L Biggs; Thomas R Austin; Stefanie Aeschbacher; Emmanuel Schaffner; Jennifer A Brody; Traci M Bartz; Martin Risch; Kirsten Grossmann; Henry J Lin; Elsayed Z Soliman; Wendy S Post; Lorenz Risch; Jose E Krieger; Alexandre C Pereira; Susan R Heckbert; Nona Sotoodehnia; Nicole M Probst-Hensch; David Conen Journal: iScience Date: 2022-09-24
Authors: Emelia J Benjamin; Alan S Go; Patrice Desvigne-Nickens; Christopher D Anderson; Barbara Casadei; Lin Y Chen; Harry J G M Crijns; Ben Freedman; Mellanie True Hills; Jeff S Healey; Hooman Kamel; Dong-Yun Kim; Mark S Link; Renato D Lopes; Steven A Lubitz; David D McManus; Peter A Noseworthy; Marco V Perez; Jonathan P Piccini; Renate B Schnabel; Daniel E Singer; Robert G Tieleman; Mintu P Turakhia; Isabelle C Van Gelder; Lawton S Cooper; Sana M Al-Khatib Journal: Circulation Date: 2021-01-25 Impact factor: 29.690
Authors: Susan R Heckbert; Paul N Jensen; Thomas R Austin; Lin Yee Chen; Wendy S Post; Bharath Ambale Venkatesh; Elsayed Z Soliman; James S Floyd; Nona Sotoodehnia; Richard A Kronmal; Joao A C Lima Journal: J Am Heart Assoc Date: 2021-02-04 Impact factor: 5.501
Authors: Matthew J Singleton; Charles A German; Mercedes Carnethon; Elsayed Z Soliman; Alain G Bertoni; Joseph Yeboah Journal: J Am Heart Assoc Date: 2020-12-31 Impact factor: 5.501
Authors: Kamala P Tamirisa; Sana M Al-Khatib; Sanghamitra Mohanty; Janet K Han; Andrea Natale; Dhiraj Gupta; Andrea M Russo; Amin Al-Ahmad; Anne M Gillis; Kevin L Thomas Journal: CJC Open Date: 2021-09-13
Authors: Utibe R Essien; Jelena Kornej; Amber E Johnson; Lucy B Schulson; Emelia J Benjamin; Jared W Magnani Journal: Nat Rev Cardiol Date: 2021-06-02 Impact factor: 32.419
Authors: Maria Papaleontiou; Deborah A Levine; David Reyes-Gastelum; Sarah T Hawley; Mousumi Banerjee; Megan R Haymart Journal: J Clin Endocrinol Metab Date: 2021-09-27 Impact factor: 6.134